Alison Bauerlein Sight Sciences, Inc. (SGHT) insider trading activity

Alison Bauerlein is Chief Operating Officer of Sight Sciences, Inc.. Currently has a direct ownership of 599,983 shares of SGHT, which is worth approximately $4.27 Million. The most recent transaction as insider was on Jan 06, 2026, when has been sold 9,647 shares (Common Stock) at a price of $7.48 per share, resulting in proceeds of $72,159. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 600K

0.41% 3M change

56.88% 12M change

Total Value Held $4.27 Million

Alison Bauerlein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 06 2026	SELL Open market or private sale	$72,159 $7.48 p/Share	9,647 Reduced 1.58%	599,983 Common Stock
Jan 05 2026	SELL Open market or private sale	$85,206 $7.82 p/Share	10,896 Reduced 1.76%	609,630 Common Stock
Nov 11 2025	BUY Grant, award, or other acquisition	-	23,006 Added 3.57%	620,526 Common Stock
Oct 02 2025	SELL Open market or private sale	$65,828 $3.3 p/Share	19,948 Reduced 3.23%	597,520 Common Stock
Jul 02 2025	SELL Open market or private sale	$78,966 $4.1 p/Share	19,260 Reduced 3.02%	617,468 Common Stock
May 19 2025	SELL Open market or private sale	$45,469 $3.48 p/Share	13,066 Reduced 2.01%	636,728 Common Stock
Apr 02 2025	SELL Open market or private sale	$44,807 $2.31 p/Share	19,397 Reduced 2.9%	649,794 Common Stock

Mar 11 2025	BUY Grant, award, or other acquisition	-	286,738 Added 30.0%	669,191 Common Stock
Jan 03 2025	SELL Open market or private sale	$35,559 $3.52 p/Share	10,102 Reduced 2.57%	382,453 Common Stock
Oct 01 2024	SELL Open market or private sale	$61,590 $6.08 p/Share	10,130 Reduced 2.52%	392,555 Common Stock
Jul 02 2024	SELL Open market or private sale	$65,186 $6.21 p/Share	10,497 Reduced 2.54%	402,685 Common Stock
May 17 2024	SELL Open market or private sale	$70,817 $5.42 p/Share	13,066 Reduced 3.07%	413,182 Common Stock
Apr 03 2024	SELL Open market or private sale	$51,424 $5.08 p/Share	10,123 Reduced 2.32%	426,248 Common Stock
Feb 14 2024	SELL Grant, award, or other acquisition	-	315,421 Reduced 41.96%	436,371 Common Stock
May 09 2023	BUY Grant, award, or other acquisition	-	103,000 Added 100.0%	0 Common Stock

Also insider at

INGN

Inogen Inc Healthcare

EVP, Finance, & CFO

PEAR

Pear Therapeutics, Inc. Healthcare

Director

GLS

GELESIS HOLDINGS, INC. Healthcare

Director